Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026)

Assembly Biosciences' Non Operating Income history runs 16 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• On a quarterly basis, Non Operating Income rose 104.01% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $7.2 million, a 42.03% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 7.59% from the prior year.
• Non Operating Income steadied at $2.3 million in Q1 2026 per ASMB's latest filing, from $2.3 million in the prior quarter.
• Across five years, Non Operating Income topped out at $2.3 million in Q4 2025 and bottomed at $71000.0 in Q1 2022.
• The 5-year median for Non Operating Income is $1.1 million (2024), against an average of $1.1 million.
• Across the five-year window, Non Operating Income jumped 757.75% in 2023 and slumped 38.57% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $583000.0 in 2022, then soared by 178.22% to $1.6 million in 2023, then slumped by 30.89% to $1.1 million in 2024, then jumped by 104.37% to $2.3 million in 2025, then changed by 0.0% to $2.3 million in 2026.
• Per Business Quant, the three latest ASMB Non Operating Income figures stand at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $1.7 million (Q3 2025).